Buy Maritupirdine Cas 1025725-91-0

Buy Maritupirdine Cas 1025725-91-0

Maritupirdine (developmental code name AVN-101), a close structural analogue of latrepirdine, is a selective 5-HT₆ receptor antagonist which is under development by Avineuro Pharmaceuticals for the treatment of Alzheimer’s disease and anxiety disorders.^[1][2][3] As of November 2013, it was in phase II clinical trials for these indications.^{[2][3][4][needs update]}

It was approved in Russia on May 31, 2023 under the brand name Aviandr for the treatment of generalized anxiety disorder, mild-to-moderate anxiety conditions (stress reactions and adjustment disorders) and anxiety after COVID-19.^[5]